| The AI in pathology market is projected to reach USD 347.4 million by 2030 from USD 107.4 million in 2025, at a CAGR of 26.5% from 2025 to 2030. The growth of the AI in pathology market is driven by the increasing adoption of digital pathology and AI-enabled telepathology that enable remote slide review, collaboration, and expert consultations among pathologists. These technologies enhance diagnostic accuracy, workflow efficiency, and access to specialized expertise. Additionally, factors such as the rising demand for advanced diagnostic technologies, growing concerns over misdiagnoses, increasing funding programs to improve patient care standards, and a strong focus on cost containment and hospital operational efficiency are further propelling market expansion.
KEY TAKEAWAYS
The North America AI in pathology market accounted for a 41.0% revenue share of the global market in 2024.
By offering, the end to end solutions segment is expected to register the highest CAGR of 26.9%.
By neural network, the Convolutional Neural Networks (CNNs) segment is projected to grow at the fastest rate from 2025 to 2030.
By function, the image analysis segment is expected to dominate the market.
By use case, the drug discovery segment will grow the fastest during the forecast period.
By end user, the pharmaceutical & biopharmaceutical companies segment is expected to dominate the market, growing at the highest CAGR of 27.6%. |
